Member Info for LordSnooty

for this year then.

"....we are the only AIM company currently invested in a medically focused Cannabis business."

Whoops? Or just from last year?

is running out....

word from the Wise (also known as the Amigos) is to be believed, and news of Factom series B is finally imminent, we could begin to see some buying interest as we run into the weekend, or perhaps early next week, in anticipation. Surely would beat the last two days of one buy and two sells.

Pred - like Matador, I have no idea whether he's a role-playing troll or not; his posts are eccentric enough but I was initially for giving him the benefit of the doubt. But my patience is at an end and I really couldn't care less whether he stays of goes now.

If, despite your claimed age and infirmities, you cannot withstand a little online argy-bargy, then I suggest it is probably a good idea to retire permanently from this forum. It is reasonable to expect, though, that a person of your age and experience will long ago have taken the trouble to inform themselves of basic market terminology, information and workings, as well as the most up-to-date data published, relating to the individual stocks they purchase.
I wish you well in your future endeavours.

RNS of 12/12/18 (three RNSs ago, see tab above):

Performance and valuation

The Company's Net Asset Value ("NAV") per share stands at 11.40p per share compared to 10.18p at 31 March 2018. Our share price moved from 18.35p per share at 31 March 2018 to 12.28p per share at 30 September 2018.

Sorry ODONNELLS, but if in your forty-seven years of trading you have not yet discovered the role of MMs (the clue is in the name) in the market, I cannot afford the time to explain. I'd have thought that your broker, at £12 per trade, would be happy to run you through Market Mechanisms 101.

In a sense it's irrelevant how many trades there are because if the news is good the MMs will push the SP to where their algorithms tell them it should be, given whatever degree of retail buying and selling occurs. But it would be nice to see some enthusiasm for the portfolio and what we know of forthcoming news, thanks to the Amigos, translated into buying. However, that doesn't appear to be the case so far.

that there is almost no retail trade of this stock today. It makes one wonder just how much of Friday's and yesterday's volume was just MM churning. I'd estimate probably 90% or more based on today's (lack of) volume.

ODONNELLS, you should invest in some of Jim Mellon's potions from Juvanescence when they become available, you'll then be able to confuse people here for another eighty years.

Go for it, man - pour encourager les autres....

Often, the difficulty arises because other trades are going through the automated system simultaneously. They usually clear and things return to normal in a few minutes, but by that time punters have often become excited, think something is up and post on what turns out to be a non-event. On another matter, looks like we are off to another cracking start today....

Peers too, might one enquire?

Doggie will be along shortly to put you straight.

playing this like a fiddle, tempting buys below the mid, false drops, late reported trades, the whole playbook.

pullback after Friday's rise. Get set for round 2.

Thank you, Chazzy. Doggie can no longer claim I post irrelevant rubbish.

Here's a handy mnemonic to help you remember the companies in our portfolio: I Just Farted Violently Despite Your Violet Lozenges

that is the question:

https://www.asiatimes.com/2019/03/article/china-censorship-and-the-blockchain-quandary/